Insulet (FRA:GOV) Defensive Interval Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:GOV Insulet Corp FRA:GOV
79 GF Score
Price €124.20
GF Value €333.00
Valuation Significantly Undervalued
View Full Analysis

What is Insulet Defensive Interval Ratio?

FRA:GOV
79GF Score
Insulet Corp FRA:GOV
Defensive Interval Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Insulet (FRA:GOV) Overvalued in 2026?

Based on GuruFocus' analysis, Insulet stock appears to be undervalued. The current stock price of €124.20 is trading 62.7% below its estimated GF Value™ of €333.00. GuruFocus considers Insulet to be Significantly Undervalued.

Key valuation signals for FRA:GOV:

  • Defensive Interval Ratio:
  • GF Value™: €333.00 vs. price of €124.20 (62.7% below fair value)
  • GF Score™: 79/100

No single metric tells the full story. See the FRA:GOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Insulet Business Description

Address 100 Nagog Park, Acton, MA, USA, 01720
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
79GF Score

Get the complete analysis for FRA:GOV

Defensive Interval Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€124.20
Price
€333.00
GF Value